Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Saved in:
| Title: | Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma. |
|---|---|
| Authors: | Meyers PA; Memorial Sloan Kettering Cancer Center, New York, NY., Federman N; University of California Los Angeles, Los Angeles, CA., Daw N; The University of Texas MD Anderson Cancer Center, Houston, TX., Anderson PM; Cleveland Clinic Children's Hospital, Cleveland, OH., Davis LE; Oregon Health and Science University, Portland, OR., Kim A; Children's National Hospital, Washington, DC., Macy ME; University of Colorado School of Medicine and Children's Hospital Colorado, Denver, CO., Pietrofeso A; Oncternal Therapeutics, Inc, San Diego, CA., Ratan R; The University of Texas MD Anderson Cancer Center, Houston, TX., Riedel RF; Duke University Medical Center, Durham, NC., Trucco M; Cleveland Clinic Children's Hospital, Cleveland, OH., Breitmeyer JB; Oncternal Therapeutics, Inc, San Diego, CA., Toretsky JA; Georgetown University, Washington, DC., Ludwig JA; The University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov; Vol. 42 (31), pp. 3725-3734. Date of Electronic Publication: 2024 Jul 02. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Multicenter Study; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
